# Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma

> **NCT02301208** · PHASE3 · UNKNOWN · sponsor: **He Xia** · enrollment: 120 (estimated)

## Conditions studied

- Nasopharyngeal Carcinoma

## Interventions

- **DRUG:** Nedaplatin
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02301208
- **Lead sponsor:** He Xia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02301208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02301208, "Weekly Cisplatin or Nedaplatin Concurrent With Intensity-modulated Radiation Therapy in Nasopharyngeal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02301208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*